The Bremelanotide Dose Question Everyone Asks (Finally Answered)

Bremelanotide at a glance:

• Drug class: Melanocortin receptor agonist
• Manufacturer: Palatin Technologies / AMAG Pharmaceuticals
• FDA approved: 2019
• Route: subcutaneous injection autoinjector
• Typical frequency: as needed before sexual activity
• Half-life: approximately 2.7 hours
• Cash price (US): $300-$1,000/month

Here's the core rule for Bremelanotide dosing: titrate slowly, hold each step long enough, and don't try to outpace your body. Approved dose: 1.

Standard Dosing Schedule for Bremelanotide

Approved dose: 1.75 mg subcutaneously at least 45 minutes before anticipated sexual activity. Maximum one dose per 24 hours, eight per month.

The typical schedule for Bremelanotide is as needed before sexual activity via subcutaneous injection autoinjector. Half-life of approximately 2.7 hours explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Bremelanotide holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Bremelanotide is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (approximately 2.7 hours) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Bremelanotide side effects and the cost angle of dose escalation in Bremelanotide cost.

What the Trials Used

Published trial data for Bremelanotide comes primarily from: RECONNECT (Kingsberg 2019, Obstet Gynecol).

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Bremelanotide: the standard contraindications for this drug class apply.

Bottom Line

Bremelanotide dosing isn't intuitive but it isn't complicated either. Follow the schedule, talk to your prescriber when something feels off, and don't make changes on your own.

Frequently Asked Questions

Related Reading

• What Is Bremelanotide? Everything You Should Know Before Starting
• Bremelanotide Side Effects: 7 Things to Watch For (and How to Manage Them)
• Bremelanotide Results: What the Real Numbers Show in 2026
• Why Bremelanotide Costs So Much (and 5 Ways to Pay Less)
• hCG: The Complete 2026 Guide (Mechanism, Dosing, Cost)
• What Is Oxytocin? Everything You Should Know Before Starting

Sources

• Skorupskaite K et al. Kisspeptin and Reproduction in Humans. Hum Reprod Update 2014;20:485.
• Kingsberg SA et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder. Obstet Gynecol 2019;134:899.

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.